Diversified Healthcare Trust
DHC Nasdaq· Real Estate Investment Trusts
Last close · Oct 26, 2026
$7.79
KIRA · Stoqly’s AI analyst, in plain words
- Diversified Healthcare Trust had $1.5B of revenue in fiscal 2025, up 2.8% on the year before. Over five years, revenue changed −1.2% a year on average.
- Diversified Healthcare Trust lost $286M in fiscal 2025.
- Diversified Healthcare Trust returned $10.8M to shareholders in fiscal 2025. The diluted share count rose 0.3%.
- Diversified Healthcare Trust owes $2.3B more than it holds in cash.
Market cap
$1.9B
P/E
—
Revenue
$1.5B
Net income
−$286M
Free cash flow
—
Operating margin
—
Diversified Healthcare Trust in 30 seconds · fiscal 2025
Are sales growing?
+2.8%
Only a little. Sales grew 2.8% last year.
Does it make a profit?
−18.6%
No. It lost money last year.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Diversified Healthcare Trust does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 24, 2026
- Legal name
- DIVERSIFIED HEALTHCARE TRUST
- CIK
- 0001075415
Diversified Healthcare Trust · DHC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.4B | $1.3B | $1.4B | $1.5B | $1.5B |
| Revenue growth | −15.2% | −7.2% | 9.9% | 6.0% | 2.8% |
| Net income | $175M | −$15.8M | −$294M | −$370M | −$286M |
| Net margin | 12.6% | −1.2% | −20.8% | −24.8% | −18.6% |
| Diluted EPS | $0.73 | −$0.07 | −$1.23 | −$1.55 | −$1.19 |
| Cash | |||||
| Cash from operations | −$63.3M | −$40.4M | $10.5M | $112M | −$19.6M |
| Dividends paid | $9.5M | $9.6M | $9.6M | $9.6M | $9.7M |
| Share buybacks | $0.4M | $0.2M | $0.4M | $0.9M | $1.1M |
| Share count change | 0.1% | 0.1% | 0.2% | 0.3% | 0.3% |
| Debt and strength | |||||
| Cash and short-term investments | $635M | $658M | $246M | $145M | $105M |
| Debt incl. finance leases | — | — | — | $3.1B | $2.4B |
| Shareholders' equity | $2.7B | $2.6B | $2.3B | $2.0B | $1.7B |
| Returns and quality | |||||
| Return on equity | 6.8% | −0.6% | −11.8% | −17.2% | −15.8% |
| Return on tangible equity | 6.7% | −0.6% | −12.7% | −19.2% | −17.4% |
| Piotroski F-score | — | — | — | — | 4 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Diversified Healthcare Trust · DHC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $7.79 a share, the company is worth $1.9B.
Source: SEC EDGAR XBRL filings (CIK 0001075415). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.